3.3. Safety evaluation
abnormal liver enzymes, abnormal liver, granulocytopenia
ADVERSE EFFECTS, GRANULOCYTOPENIA, UTI
The most prevalent adverse effects of UTI include granulocytopenia and abnormal liver enzymes. We found that 10 (8.33%) patients experienced granulocytopenia in the UTI group, while 6 (5.04%) patients experienced granulocytopenia in the placebo group, with no significant difference between the 2 groups. There were 21 (17.65%) cases of abnormal liver enzymes in the control group, while there were 39 (32.50%) cases of abnormal liver enzymes in the UTI group, which was significantly higher than the placebo group (Comparison of safety evaluation, and postoperative hospital stays and costs.CNY = Chinese Yuan, SD = standard deviation, UTI = ulinastatin.